Gateway Analytical

Gateway Analytical | March 07, 2016

Gateway Analytical announced today that they will give a scientific poster presentation on proactive and reactive glass delamination analysis in addition to exhibiting at the upcoming 2016 Parenteral Drug Association (PDA) Annual Meeting and Exposition in San Antonio, Texas. The 2016 PDA Annual Meeting features some of the latest and most inclusive....

Gateway Analytical | December 12, 2016

Gateway Analytical, one of the world’s most trusted particle identification and characterization laboratories, now offers complete foreign particulate testing, identification and analysis services for cytotoxic drug products. The new service is available immediately....

Gateway Analytical | April 06, 2017

Gateway Analytical announced today that they will be exhibiting and presenting at the upcoming Respiratory Drug Delivery (RDD) conference in Phoenix....

Pharmacy Business | January 14, 2020

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...